We Should at Least Be Able to Design Molecules That Dock Well by Cieplinski, Tobiasz et al.
We Should At Least Be Able To Design Molecules That
Dock Well
Tobiasz Cieplinski1, Tomasz Danel1, Sabina Podlewska1,
Stanisław Jastrzębski23
Abstract
Designing compounds with desired properties is a key element of the drug discovery
process. However, measuring progress in the field has been challenging due to the lack
of realistic retrospective benchmarks, and the large cost of prospective validation. To
close this gap, we propose a benchmark based on docking, a popular computational
method for assessing molecule binding to a protein. Concretely, the goal is to generate
drug-like molecules that are scored highly by SMINA, a popular docking software. We
observe that popular graph-based generative models fail to generate molecules with a
high docking score when trained using a realistically sized training set. This suggests
a limitation of the current incarnation of models for de novo drug design. Finally, we
propose a simplified version of the benchmark based on a simpler scoring function, and
show that the tested models are able to partially solve it. We release the benchmark
as an easy to use package available at https://github.com/cieplinski-tobiasz/smina-
docking-benchmark. We hope that our benchmark will serve as a stepping stone to-
wards the goal of automatically generating promising drug candidates.
1 Introduction
Designing compounds with some desired chemical properties is the central challenge in the
drug discovery process [Sliwoski et al., 2014, Elton et al., 2019]. De novo drug design is
one of the most successful computational approach that involves generating new potential
ligands from scratch, which avoids enumerating explicitly the vast space of possible struc-
tures. Recently, deep learning has unlocked new progress in drug design. Promising results
using deep generative models have been shown in generating soluble [Kusner et al., 2017a],
bioactive [Segler et al., 2018], and drug-like [Jin et al., 2018b] molecules.
A key challenge in the field of drug design is the lack of realistic benchmarks [Elton et al.,
2019]. Ideally, the generated molecule by a de novo method should be tested in the wet lab
for the desired property. In practice, typically, a proxy is used. For example, the octanol-
water partition coefficient or bioactivity is predicted using a computational model [Segler
et al., 2018, Kusner et al., 2017a]. However, these models are often too simplistic [Elton
et al., 2019]. This is aptly summarized in Coley et al. [2019] as “The current evaluations for
generative models do not reflect the complexity of real discovery problems.”. In contrast to
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Figure 1: Visualization of the proposed docking-based benchmark for de-novo drug design
methods. First, the proposed molecule (leftmost) is docked to the target’s binding site using
SMINA, a popular docking software. In the most difficult version of the benchmark, the
final score is computed based on the ligand pose using the default SMINA docking score.
drug design, more realistic benchmarks have been used in the design of photovoltaics [Pyzer-
Knapp et al., 2015] or in the design oof molecules with certain excitation energies [Sumita
et al., 2018], where a physical calculation was carried out to both train models, and to
evaluate generated compounds.
Our main contribution is a realistic benchmark for de novo drug design. We base our
benchmark on docking, a popular computational method for predicting molecule binding to a
protein. Concretely, the goal is to generate molecules that are scored highly by SMINA [Koes
et al., 2013]. We picked Koes et al. [2013] due to its popularity and being available under a
free license. While we focus on de novo drug design, our methodology can be extended to
evaluate retrospectively other approaches to designing molecules. Code to reproduce results
and evaluate new models is available online at https://github.com/cieplinski-tobiasz/smina-
docking-benchmark.
Our second contribution is exposing limitation of currently popular de novo drug design
methods for generating bioactive molecules. When trained using a few thousands com-
pounds, a typical training set size, the tested methods fail to generate active structures
according to the docking software. This suggest we should exercise caution when applying
them in drug discovery pipelines, where we seldom have larger number of known ligands.
We hope our benchmark will serve as a stepping stone to further improve these promising
models.
The paper is organised as follows. We first discuss prior work and introduce our bench-
mark. Next, we use our benchmark to evaluate two popular models for de novo drug design.
Finally, we analyse why the tested models fail on the most difficult version of the benchmark.
2 Docking-based benchmark
We begin by briefly discussing prior work and motivation. Next, we introduce our bench-
mark.
2.1 Why do we need yet another benchmark?
Standardized benchmarks are critical to measure progress in any field. Development of
large-scale benchmarks such as the ImageNet was critical for the recent developments in
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artificial intelligence [Deng et al., 2009, Wang et al., 2018]. Many new methods for de novo
drug design are conceived every year, which motivates the need for a systematic and efficient
way to compare them [Schneider and Clark, 2019].
De novo drug design methods are typically evaluated using proxy tasks that circumvent
the need to test the generated compounds experimentally [Jin et al., 2018a, You et al., 2018,
Maziarka et al., 2020, Kusner et al., 2017b, Gómez-Bombarelli et al., 2016]. Optimizing the
octanol-water partition coefficient (logP) is a common example. The logP coefficient is
commonly computed using an atom-based method that involves summing contribution of
individual atoms [Wildman and Crippen, 1999, Jin et al., 2018a], which is available in the
RDKit package [Landrum, 2016]. Due to the fact that it is easy to optimize the atom-based
method by producing unrealistic molecules [Brown et al., 2019], a version that heuristically
penalizes hard to synthesize compounds is used in practice [Jin et al., 2018a]. This example
illustrates the need to develop more realistic ways to benchmark these methods. Another
example is QED score [Bickerton et al., 2012] which is designed to capture druglikeliness
of a compound. Finally, some approacches use a model (e.g. a neural network) to predict
bioactivity of the generated compounds Segler et al. [2018]. Similarly to logP, these two
tasks are also possible to optimize while producing unrealistic molecules. This is aptly
summarized in Coley et al. [2019] as
“The current evaluations for generative models do not reflect the complexity of
real discovery problems.”
Interestingly, besides the aforementioned proxy tasks, more realistic proxy tasks are
rarely used in the context of evaluating de novo drug design methods. This is in contrast
to evaluation of generative models for generating photovoltaics [Pyzer-Knapp et al., 2015]
or molecules with certain excitation energies [Sumita et al., 2018]. One notable exception
is Aumentado-Armstrong [2018] who try to generate compounds that are active according
to the DrugScore [Neudert and Klebe, 2011], and then evaluate the generated compounds
using rDock [Ruiz-Carmona et al., 2014]. This lack of the overall diversity and realism in
the typically used evaluation methods motivates us to propose our benchmark.
2.2 Docking-based benchmark
Our docking-based benchmark is defined by: (1) docking software that computes for a
generated compound its pose in the binding site, (2) a function that scores the pose, (3) a
training set of compounds with an already computed docking score.
The goal is to generate a given number of molecules that achieve the maximum possible
docking score. For the sake of simplicity, we do not impose limits on the distance of the
proposed compounds to training set. Thus a simple baseline is to return the training set.
Finding similar compounds that have a higher docking score is already prohibitively chal-
lenging for current state-of-the-art methods. As the field progresses, our benchmark can
be easily extended to account for the similarity between the generated compounds and the
training set.
Finally, we would like to stress that the benchmark is not limited to de novo methods.
The benchmark is applicable to any other approaches such as virtual screening. The only
limitation required for a fair comparison is that docking is performed only on the supplied
training set.
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2.3 Instantiation
As a concrete instantiation of our docking-based benchmark, we use SMINA [Koes et al.,
2013] due to its wide-spread use and being offered under a free license. To create the
training set, we download from the ChEMBL [Gaulton et al., 2016] database molecules
tested against popular drug-targets: 5-HT1B, 5-HT2B, ACM2, and CYP2D6. For 5-HT1B
the final dataset consists in 1891 molecules, out of which 1148 are active (Ki < 100nm) and
743 are inactive molecules (Ki > 1000nm). We list sizes of the datasets in Table 2.
We dock each molecule using default settings in SMINA to a manually selected binding
site coordinate. Protein structures were downloaded from the Protein Database Bank,
cleaned and prepared for docking using Schrodinger modeling package. The resulting protein
structures are provided in our code repository. We describe further details on the preparation
of the datasets in Appendix C.
Starting from the above, we define the following three variants of the benchmark. In
the first variant, the goal is to propose molecules that achieve the smallest SMINA docking
score used in score only mode, defined as follows:
Docking score =− 0.035579 · gauss(o = 0, w = 0.5)
− 0.005156 · gauss(o = 3, w = 2)
+ 0.840245 · repulsion
− 0.035069 · hydrophobic
− 0.587439 · non_dir_h_bond
,
where all terms are computed based on the final docking pose. The first three terms
measure the steric interaction between ligand and the protein. The fourth and the fifth term
look for hydrophobic and hydrogen bonds between the ligand and the protein. We include
in Appendix A a detailed description of all the terms.
Next, we propose two simpler variants of the benchmark based on individual terms in the
SMINA scoring function. In the Repulsion task, the goal is to only minimize the repulsion
component, which is defined as:
repulsion(a1, a2) =
{
ddiff(a1, a2)
2, ddiff(a1, a2) < 0
0, otherwise
where ddiff(a1, a2) is the distance between the atoms minus the sum of their van der
Waals radii. Distance unit is Angstrom (10−10m).
The third task, Hydrogen Bond Task, is to maximize the non_dir_h_bond term:
non_dir_h_bond(a1, a2) =

0, (a1, a2) do not form hydrogen bond
1, ddiff(a1, a2) < −0.7
0, ddiff(a1, a2) ≥ 0
ddiff(a1,a2)
−0.7 otherwise.
To make the results more stable, we average the score over the top 5 best-scoring binding
poses. Finally, to make the benchmark more realistic, we filter the generated compounds
using the Lipinski rule, and discard molecules with molecular weight lower than 100.
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3 Results and discussion
In this section, we evaluate two popular models for de novo drug design on our benchmark.
3.1 Models
We compare two popular models for de novo drug design. Chemical Variational Autoen-
coder (CVAE) [Gómez-Bombarelli et al., 2018] applies Variational Autoencoder [Kingma and
Welling, 2013] by representing molecules as strings of characters (using SMILES encoding).
This approach was later extended by Grammar Variational Autoencoder (GVAE) [Kusner
et al., 2017a], which ensures that generated compounds are grammatically correct.
3.2 Experimental details
To generate active compounds, we follow a similar approach to in Gómez-Bombarelli et al.
[2018] and Kusner et al. [2017a]. First, we fine-tune a given generative model for 5 epochs
on the training set ligands, starting from weights made available by the authors1. All
hyperparameters are set to default values used in Gómez-Bombarelli et al. [2018] and Kusner
et al. [2017a]. Additionally, we use the provided scores to train a multilayer perceptron
(MLP) to predict the target (e.g. the SMINA scoring function) based on the latent space
representation of the molecule.
To generate compounds, we first take a random sample of the model latent space by
sampling from a Gaussian distribution with the standard deviation of 1 and the mean of 0.
Starting from this point in the latent space, we take Z gradient steps to optimize the output
of the MLP. Based on this approach we generate 250 compounds from the model.
All other experimental details, including hyperparameter values used in the experiments,
can be found in Appendix B.
In the experiments, we compare to three baselines: (1) random compounds from ZiNC,
(2) random unseen in training active compounds (Ki < 100nm), (3) random unseen in
training inactive compounds (Ki > 1000nm).
3.3 Results
In this section, we use the above procedure to generate compounds for the three targets
defined in Section 2.3. Table 1a summarizes the results on all three tasks. Below we make
several observations.
First, we observe that CVAE and GVAE models fail to generate compounds that achieve
higher scores than the three baselines. In particular, both models produce compounds
that achieve on average docking scores below the mean in the training set (−8.267). Even
looking at the Top 1%, the achieved scores are below the mean. This is reminiscent of
results in Gao and Coley [2020]. They show that de novo models tend to generate difficult
to synthesize molecules, even if optimizing for a proxy of synthesability. Similarly, even
though we optimize for docking score using the MLP, the models fail to optimize the actual
score. We will analys this phenomenon more closely in Section 3.4.
The next two tasks are easier to solve. On the Repulsion task, both models improve
upon the baselines. GVAE generates compounds with remarkably low repulsion that is an
1Available at https://github.com/aspuru-guzik-group/chemical_vae/tree/master/models/zinc and at
https://github.com/mkusner/grammarVAE/tree/master/pretrained.
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5HT1B 5HT2B ACM2 CYP2D6
ZiNC -8.241 (-12.068) -8.303 (-14.477) -7.587 (-11.533) -6.873 (-10.601)
Inactives -7.707 (-11.306) -8.375 (-11.212) -6.971 (-10.451) -6.992 (-10.76)
Actives -8.727 (-12.294) -8.527 (-14.38) -8.156 (-11.532) -6.866 (-8.869)
CVAE -4.888 (-8.942) -5.349 (-9.767) -5.138 (-7.600) -4.829 (-7.719)
GVAE -4.681 (-7.507) -4.139 (-6.983) -5.156 (-7.869) -5.425 (-7.590)
(a) Score Function task
5HT1B 5HT2B ACM2 CYP2D6
ZiNC 3.438 (0.571) 2.559 (0.557) 5.200 (0.517) 5.716 (0.604)
Inactives 3.092 (0.548) 2.368 (0.616) 4.781 (0.601) 5.828 (0.787)
Actives 3.688 (1.417) 2.729 (0.785) 5.531 (0.911) 5.186 (0.995)
CVAE 0.717 (0.105) 0.741 (0.034) 0.806 (0.076) 1.900 (0.145)
GVAE 1.200 (0.039) 0.686 (0.017) - -
(b) Repulsion task
5HT1B 5HT2B ACM2 CYP2D6
ZiNC 1.547 (4.983) 0.971 (3.379) 1.012 (5.805) 0.634 (4.533)
Inactives 1.258 (3.358) 0.945 (3.216) 0.948 (5.455) 0.689 (4.363)
Actives 1.698 (4.994) 1.095 (3.037) 1.124 (4.025) 0.475 (1.551)
CVAE 1.234 (5.059) 0.818 (3.585) 0.717 (4.241) 0.583 (4.620)
GVAE 2.581 (11.225) 2.111 (6.525) 2.771 (10.071) 2.339 (7.548)
(c) Hydrogen Bonding task
Table 1: Benchmark results. In Score Function, the goal is to propose 250 compounds
achieving the lowest mean SMINA docking score towards a given target. Each cell reports
the mean score for all compounds, and for the top 1% of compounds in the parenthesis.
We observe that for Score Function task CVAE and GVAE fail to outperform ZiNC (a
random sample of 250 compounds from the ZiNC database). Missing results ("-") indicate
that the model failed to generate 250 molecules that satisfy the drug-like filters (described
in the text).
order of magnitude lower (0.039) than the best score observed in the training set (0.322).
This however should be interpreted with caution. It is possible to minimize repulsion by
avoiding docking to the binding site, which might explain why Inactives tend to have lower
repulsion than Actives. As such we suggest to treat the Repulsion task as a form of a unit
test for the validity of the generating procedure.
The Hydrogen Bond task difficulty lies between the first two tasks. The mean score
of molecules generated by GVAE is 1.52 times larger than the mean score of Actives (2.24
times larger for Top 1%). Contrarily, CVAE Top 1% results are worse the ones in Inactives
dataset. This suggests that maximizing the non_dir_h_bond term in Equation A is harder
than minimizing the repulsion term, but is still an easier task than optimizing the whole
docking score.
Stronger results on the Repulsion and Hydrogen Bond tasks show it is feasible to
optimize individual components of the score. This suggests that solving SMINA Score
task is an attainable goal.
Finally, our results also suggest that generative models applied to de novo drug discovery
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5HT1B 5HT2B ACM2 CYP2D6
Dataset size 1891 1194 2341 4200
Table 2: Sizes of the dataset used in the benchmark. The corresponding test dataset
comprises of 10% of the whole dataset, and the rest of it is used in training.
pipelines might require substantial more data to generate active compounds than is typically
available for training. In particular on the 5-HT1B receptor, despite using a realistically
sized training set of over one thousand compounds, the achieved docking scores are worse
than in a random sample from the ZiNC dataset. Docking score is only a simple proxy of
the actual binding affinity, and as such it should worry us that it is already challenging to
optimize.
3.4 Analysis
In this section, we investigate why do CVAE and GVAE models fail to generate compounds
that achieve high docking scores.
The most natural hypothesis is that predicting docking score is difficult. Our procedure
uses the gradient of the MLP to generate active compounds. If the model fails at predicting
activity, it is reasonable to assume it also fails to guide the generating process towards active
compounds.
5HT1B 5HT2B ACM2 CYP2D6
CVAE -60.071 (-58.792) -28.958 (-30.205) -354.084 (-352.818) -515.886 (-377.572)
GVAE -36.565 (-25.608) -50.412 (-47.629) -66.009 (-53.335) -55.021 (-47.307)
Table 3: Predicted docking score towards 5HT1B by the MLP for the compounds presented
in Table 1a. Comparing to Table 1a, we can observe that the predicted docking scores are
two, three or even four orders of magnitude overestimating the true activity.
Recall that both models failed to generate compounds that achieve better docking scores
towards 5HT1B than in particular a random sample from the ZiNC dataset (see Table 1a).
However, the MLP predicts that these compounds are active towards 5HT1B. We show this
in Table 3. This discrepancy between MLP predictions and actual docking scores strongly
suggest that modeling the docking score is the bottleneck.
To better quantify this effect, we measure the root mean squared error (MSE) between
the predicted and the true docking score on two datasets: (1) 100 random samples of latent
space from Gaussian distribution (Gauss), and (2) 250 molecules generated using gradient
latent space optimization (Generated). We compare this to SMINA by redocking compounds
and measuring the discrepancy between the two docking runs (SMINA).
Table 4 reports the results, and Figure 2 shows the predicted docking score against the
true docking score on the compounds generated by CVAE. We observe that on all subsets
the RMSE is three to four orders of magnitude higher than RMSE between two docking runs
(SMINA). This shows that using better models for predicting docking scores is a promising
avenue for improving results on the benchmark.
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MLP SMINA
Gauss 4.064 0.004
Generated 56.062 0.009
(a) CVAE
MLP SMINA
Gauss 8.24 0.004
Generated 33.646 0.018
(b) GVAE
Table 4: Root mean square error between the predicted and the true docking scores for
CVAE (left) and GVAE (right), compared to the difference between two runs of the docking
software (SMINA).
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Figure 2: The predicted docking score (y axis) versus the true docking score (x axis) for the
250 compounds generated by CVAE. Improving modeling of the docking score is a promising
avenue for improving on the benchmark.
4 Conclusion
As concluded by Coley et al. [2019], “the current evaluations for generative models do not
reflect the complexity of real discovery problems”. In this work, we proposed a new, more
realistic, benchmark tailored to de novo drug design using docking score as the target
to optimize. Code to evaluate new models is available at https://github.com/cieplinski-
tobiasz/smina-docking-benchmark.
Our results also suggest that generative models applied to de novo drug discovery
pipelines might require substantial more data to generate realistic compounds than is typi-
cally available for training. Despite using over 2000 compounds for training (for the CYP2D6
target), the achieved docking scores are worse than in a random sample from the ZiNC
dataset. Docking score is only a simple proxy of the actual binding affinity, and as such it
should worry us that it is already challenging to optimize.
On a more optimistic note, the tested models were able to optimize the number of
hydrogen bonds to the binding site, which is a term in the SMINA scoring function. This
suggests that producing compounds that optimize docking score based on the provided
dataset is an attainable, albeit challenging, task. We hope our benchmark better reflects
“the complexity of real discovery problems“ and will serve as a stepping stone towards
developing better de novo models for drug discovery.
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A Default SMINA scoring function
We include the definitions of SMINA’s default scoring function components and weights
used for calculating docking score in score only mode. a1 and a2 denote atoms, d(a1, a2) is
the distance between atoms, dopt is the sum of their van der Waals radii and ddiff(a1, a2) =
d(a1, a2)− dopt(a1, a2). Distance unit is Angstrom (10−10m).
Docking score =− 0.035579 · gauss(o = 0, w = 0.5)
− 0.005156 · gauss(o = 3, w = 2)
+ 0.840245 · repulsion
− 0.035069 · hydrophobic
− 0.587439 · non_dir_h_bond
gauss(a1, a2) = exp
(
−
(
ddiff(a1, a2)− o
w
)2)
repulsion(a1, a2) =
{
ddiff(a1, a2)
2, ddiff(a1, a2) < 0
0, otherwise
hydrophobic(a1, a2) =

0, not_hydrophobic(a1) or not_hydrophobic(a2)
1, ddiff(a1, a2) < 0.5
0, ddiff(a1, a2) ≥ 1.5
1.5− ddiff(a1, a2), otherwise
non_dir_h_bond(a1, a2) =

0, (a1, a2) do not form hydrogen bond
1, ddiff(a1, a2) < −0.7
0, ddiff(a1, a2) ≥ 0
ddiff(a1,a2)
−0.7 , otherwise
B Model details
We include hyperparameters and training settings used in our models. Our code is available
at https://github.com/cieplinski-tobiasz/smina-docking-benchmark.
MLP is used to predict docking score from CVAE or GVAE latent space representation of
molecule. It is a simple feed forward neural network with one hidden layer. Hyperparameters
of this model are listed in 5.
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Parameter
Training epochs 50
Layers number 1
Hidden layer dim 1000
Loss function Mean Squared Error
Optimizer Adam
Learning rate 0.001
Table 5: MLP hyperparameters
Both Chemical VAE and Grammar VAE are based on variational autoencoder model
with stacked convolution layers in its encoder part and stacked GRU layers in decoder part.
What differs them is the way that SMILES is encoded to one hot vector. Chemical VAE
encodes each character of SMILES to separate one-hot vector, while Grammar VAE forms
a parse tree from SMILES and encodes the parse rules. Details for CVAE are listed in 6
and for GVAE in 7.
Parameter
MLP learning rate 0.05
MLP descent iterations 50
Fine-tuning batch size 256
Fine-tuning epochs 5
Latent space dim 196
Encoder convolution layers number 4
Decoder GRU layers number 4
Table 6: Chemical VAE hyperparameters
Parameter
MLP learning rate 0.01
MLP descent iterations 50
Fine-tuning batch size 256
Fine-tuning epochs 5
Latent space dim 56
Encoder convolution layers number 3
Decoder GRU layers number 3
Table 7: Grammar VAE hyperparameters
C Dataset details
The compound sets were downloaded from the ChEMBL database. All records referring to
human- and rat-based records were taken into account. Compunds with Ki values below
100 nM (later referred to as active compounds) and above 1000 nM (inactive ones) were
taken into account. Only binding data were considered, it was assumed that IC50 = Ki/2.
The compound protonation states were generated for pH = 7.4.
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The crystal structures for docking were fetched from the PDB database, the following
structures were used in the study: 4IAQ for 5-HT1B, 4NC3 for 4-HT2B, 3UON for ACM2,
and 3QM4 for CYP3D6. The Protein Preparation Wizard from the Schrodinger molecular
modeling package was used for protein preparation for docking.
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